chrisvoncsefalvay/vaers-outcomes huggingface dataset:
headache; chills; ache; This is a spontaneous report from a contactable consumer (patient). A 71 years-old female patient (not pregnant at the time of vaccination) received second dose of BNT162B2 (Solution for Injection, lot number: EL9269, Expiration date: unknown), via an unspecified route of administration on 26Feb2021, at 06:00 PM (at 71-years-age) as 2nd dose, single dose for covid-19 immunisation and received first dose of BNT162B2 (Solution for Injection, lot number, Expiration date: unknown), via an unspecified route of administration on an unspecified date as 1st dose, single dose for covid-19 immunisation. Other vaccination date reported as Feb2021. The patient medical history and concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks previous to the COVID vaccine. On an unspecified date, the patient experienced headache, chills and aches after 24 hours of vaccination. No Treatment received for the events. The outcome of the events was recovered.   No follow-up attempts are possible. No further information is expected.
Post Tdap and Hep A vaccinations patient told RN she felt "woozy", had tonic clonic seizure lasting 30-45 seconds. Code blue was called, EMS called. Fingerstick 133, VS stable. Placed on non-rebreather o2. Several minutes later pt again didn't feel well, had second seizure lasting about 10-15 seconds. Post seizure was +diaphoretic, spotty vision, pale. Was not postictal after either seizure, was able to recall what happened, understood where she was.  No vomiting, loss of urine.  Reports she felt like she was dreaming during the seizure. Denied chest pain, dyspnea. Sent to ER via ambulance
Redness, swelling, warm to touch, itching, irritability, decrease appetite, Swelling continued to increase.
Diarrhea for 4-5 hours starting about 6p until 10-11p. Horrendous am pain at the injection site, I couldn't even lift my arm above my shoulder. Also, the palms of my hands were incredibly itchy
Fatigue, polyarticular inflammatory arthritis, abdominal pain, constipation, headaches, dizziness, fainting, joint pain, unexplained rapid weight gain, skin rash, hair loss, sun sensitivity, swelling of legs hands and feet.
Patient complaints two days after she got the single shot (April 16, 2016) she has rashes developed on both of her palms and sometime they're inflamed.
pt recvd vax; 19nov94 t 101; reddened swollen area on upper arm;reddened down to elbow;
Severe drowsiness x 2 days. Severe dizziness x 2 days. Pain in arm x 2 days.
Information has been received from a healthcare worker concerning an 81 year old female patient (79 year old reported) who on 14-DEC-2010 was vaccinated with a 0.5ml dose of VARIVAX (Merck) (Lot#665004/0929Y) (Exp date. 11-JUN-2013), SQ. The healthcare worker stated that the patient received VARIVAX (Merck) instead of ZOSTAVAX (Merck). No adverse effect reported. Additional information has been requested.
has contracted Covid; has contracted Covid; This is a spontaneous report received from contactable consumer (patient herself) via medical information team. A 53-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection and Lot Number: unknown) via an unspecified route of administration on 10Mar2021 as a single dose for COVID-19 immunization. Medical history and Concomitant medications were not reported. On an unspecified date, the patient had contracted Covid. Patient was scheduled to receive her second vaccine on 31Mar2021. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
06/13/2022 I threw up and was nauseous that evening. I began having congestion the next day and could feel it going into my lungs. I tested on 6/15/2022 and was positive with two home COVID tests. I saw my doctor that afternoon and was prescribed Paxlovid. I took the first dose that evening and within an hour I could feel a difference in my lungs, it was getting better already. I took the Paxlovid for the 5 days. Within a few days after I completed the Paxlovid, I felt good.  I had been traveling and tested negative on 6/11/2022.
From initial information received on 06/02/2004 from a healthcare professional regarding an adverse event occurring in the USA, it was reported that a 22 year old female patient received a TD ADS Adult vaccination, lot number U1024AA, administered intra-muscularly in the right arm on 05/30/2004.  Two days later, on 06/01/2004, the patient developed redness, low-grade fever and nausea.  she also experienced chest tightness the night of 06/01/2004.  She was treated with Slovent and her recovery status was reported as unknown.  The patient was pregnant at the time of vaccination and her past medical history was significant for asthma and allergies to citalopram and sulfa.
Dizzy spells, lightheadedness,  tinnitus. Tinnitus continues 24/7, dizziness subsiding.
Post vaccine, patient was being observed and reported dizziness and tremor of the hands.  EMS assessed and the patient was transferred to the ED  via ambulance.
Prolonged malaise, fatigue, and myalgia and injection site pain that is still present 8 days from  injection. Still with some malaise and fatigue to date although the severity has diminished. Some mild injection site discomfort still present.
2/22 Local reaction -quarter size with central broken vesicle on (L) lat. thigh . 2/23/10 Red indurated pruritic area larger than yesterday.
intense headache started two days; Intense swelling of legs/weakness worse than first incident; Intense swelling of legs/weakness worse than first incident; This is a spontaneous report received from contactable reporter (Consumer). The reporter is the patient.  A 65-year-old female patient (not pregnant) received BNT162B2 (BNT162B2), administered in arm left, administration date 08Apr2021 (Batch/Lot number: unknown) at the age of 65 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "high blood pressure" (unspecified if ongoing). Concomitant medication(s) included: LISINOPRIL; HYDROCHLOROTHIAZIDE. Vaccination history included: BNT162B2 (Dose 1, Single, Lot number: EN6207, Administration Time: 13:30, Vaccine Location: Left arm), administration date: 18Mar2021, when the patient was 64 years old, for Covid-19 Immunization, reaction(s): "hard to bend weakness in legs"; BNT162B2 (Dose 1, Single, Lot number: EN6207, Administration Time: 13:30, Vaccine Location: Left arm), administration date: 18Mar2021, when the patient was 64 years old, for Covid-19 Immunisation, reaction(s): "Intense headache frontal lobe", "Intense swelling of legs", "hard to bend weakness in legs". The following information was reported: HEADACHE (non-serious) with onset Apr2021, outcome "not recovered", described as "intense headache started two days"; PERIPHERAL SWELLING (non-serious), MUSCULAR WEAKNESS (non-serious) all with onset Apr2021, outcome "recovering" and all described as "Intense swelling of legs/weakness worse than first incident". Therapeutic measures were not taken as a result of headache, peripheral swelling, muscular weakness. Additional Information: The patient did not receive any other vaccine in four weeks. On 2nd shot, the patient experienced intense headache started two days after, still present; intense swelling of legs/weakness worse than first incident, happened within 5 hours of shot lasted 24 hours still minor swelling. The patient has not been diagnosed with COVID-19 prior vaccination and has not been tested for COVID-19 post vaccination. The patient has no known allergies.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021437779 same drug/reporter/patient, different dose
Redness, warmth to right thigh 7.5x4.5 inches. Treatment at ER, given Keflex for 10 days and Benadryl as needed. Follow up at primary care office.
Myalgia, Arthralgia, NauseaVomiting, fatigue Narrative:
Patient is fully vaccinated. 33-year-old male presents to the ED complaining of COVID-19 symptoms.  Patient states that his symptoms began approximately 10 days ago, and he tested positive for COVID-19 1 week ago.  He states that he has been experiencing worsening, generalized body aches, intermittent fevers and chills, congestion, cough and intermittent shortness of breath since that time.  Patient states that he has been experiencing nausea today but denies any episodes of vomiting.  Patient discharged from ED.  Patient returned to ED on 2.6 with Diabetic ketoacisosi. Presented with difficulty breathing and change of mentation.  "The patient was found to be in DKA with almost normal sugar."  Glucose level 194. The patient was  on xfarsiga anf  metformin.The patient is on IV drip of insulin with half normal saline with D5. Clinically stable and discharged home.
Nausea, upper and lower abdominal pain, severe full body myalgia, lethargy, low back pain, malaise/ extreme fatigue, chills, difficulty concentrating, depressed mood.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 05-SEP-2018, the patient was vaccinated with an improperly stored dose of GARDASIL 9 (strength and route were unknown) (lot# N032956 and expiration date 13-JUL-2020) for prophylaxis (Incorrect product storage). No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001957: US-009507513-1810USA001958: US-009507513-1810USA001959: US-009507513-1809USA003709.
10/13/20-shot administered, early evening pain in left hand between thumb and index finger( lower area), a bit later exact pain in the exact place on right hand, left arm was sore due to injection, pain in left elbow, neck and spine felt achy and my right knee ached,  at one point my right TMJ joint hurt ( my inner right ear ached but it went away quickly). I felt extremely tired. Next morning left thumb feeling better but right was worse, spine still achy as well as my neck, arm still sore. I took Tylenol ( extra strength) as advised. Sent message to dr. but didn't go through, again on 10/21/20' right thumb pain seemed to be worse than left but I felt perhaps better and now it is a week later. 10/23/20' my wrists
10PM pt had 1 convuls lasting 2 mins, EMT's called pt transported to ER where pt was txed w/APAP & Ibuprofen & released; T102.9 @ ER;
pt recv vax & exp inconsolable crying for 4-5 hr afterward;this is 1 of 4 pt reported from the same site w/this rxn
w/in 24 hrs p/DTP/OPV/HIB, pt exp fever of 104, irritability & an inject site react (redness); tx included APAP; @ time of this report, mom reports that pt has a temp 102;
about 3 hrs p/vax was given pt devel a fever of 105 & a red swollen buttocks; pt cried for 2 hrs & unable to be consoled;
I NOTICED A PAINFUL LYMPH UNDER MY LEFT ARM- LASTED A MONTH; THE SIZE WAS ABOUT 10 CENTIMETERS I GOT A STERIOD SHOT FROM THE BREAST SPECIALIST BETWEEN 3WEEKS TO MONTH FOLLOWING THE VACCINATION TO HELP WITH THE PAIN.
This case was considered medically important (OMIC). Information regarding Hib Titer vaccine (haemophilus b conjugate vaccine (diphtheria crm197 protein conjugate) injection) was received from a healthcare professional regarding a female pt (currently 8 years old) who experienced autism at the age of 3. The pt received the fourth dose on 07Nov97. Relevant medical history was not provided. Indication for Hib Titer vaccine was immunization. Product was administered on 07Nov97. Dose regimen was 1 dose (IM). Additional suspect medications included Varivax, MMR, Polio vaccine, Hep B vaccine and AcelImmune Vaccine. Concomitant medications were not reported. The reporter stated that the pt was diagnosed with autism in Feb2000 with symptoms of speech delay and behavior issues starting at the age of 3. No additional information was available at the time of this report. Information regarding this event has been forwarded to the manufacturers of the concomitantly administered vaccines.
Vomiting; diarrhea; headache; chills; sweating; slept all day; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: En6208), administered in left arm, on 10Mar2021 at 11:00 AM (at the age of 61-years-old) at 1st dose, single dose for COVID-19 immunisation. The patient was not pregnant. Medical history included known allergies to penicillin. The patient had not COVID prior vaccination and was not tested for COVID post vaccination. Concomitant medications were not reported. No other vaccine received in four weeks. The patient previously took aspirin and experienced allergies. The patient experienced vomiting, diarrhea, headache, chills, sweating, slept all day on 11Mar2021 at 01:00 AM. No treatment was administered for the adverse events. The patient had recovered with lasting effects from the events in Mar2021.   No follow-up attempts are possible. No further information is expected.
Fast Heartbeat; Warm allover - first in chest and then rest of the body; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Fast Heartbeat) and FEELING HOT (Warm allover - first in chest and then rest of the body) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HEART RATE INCREASED (Fast Heartbeat) and FEELING HOT (Warm allover - first in chest and then rest of the body). On 12-Mar-2021, HEART RATE INCREASED (Fast Heartbeat) and FEELING HOT (Warm allover - first in chest and then rest of the body) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment details not provided She was being monitored for 30 minutes for event. Consent provided for safety follow-up.
This spontaneous report as received from a female pharmacist of unknown age referring to herself with AUGMENTIN allergy. On an unknown date in 1999 (also reported as about 15 years ago), the patient was vaccinated with VARIVAX (merck) dose 1, route not reported. No concomitant medication reported. On an unknown date, the patient experienced difficulty breathing and rash all over her body. In addition, on an unknown date in 1999 (also reported as the same day of the VARIVAX (merck) vaccination), pharmacist states she also may have inhaled some aerosolization of VARIVAX (merck) when she opened the vial, before she reconstituted the vaccine to administer to a patient. Pharmacist also stated that she went to the emergency room and was treated with albuterol, Epinephrine, prednisone, and was released. Pharmacist was not hospitalized. Pharmacist never received the second dose of VARIVAX (merck) (vaccination). Pharmacist had recovered from difficulty breathing and rash all over her body. Causality between VARIVAX (merck) (vaccination) and the events difficulty breathing and rash all over her body was not reported. The events of difficulty breathing and rash all over her body was reported as life threatening. Additional information has been requested.
1--fever and fatigue all next day.   2--1" bruise remains 8 days later
Exactly 7 days after receiving the Moderna vaccine I began to have itching in my arm in the evening.  It was similar to having a mosquito bite where you itch like crazy.  I didn't do anything about it and the next morning I had a huge blotch on my arm that I now know to be "covid arm."  It was like a huge red blotch that hurt to the touch.
Report received from a nurse on 06-OCT-2010 (received via Merck WAES: 1009USA00666). A 44 year old female patient received a 0.5ml dose of AFLURIA injection (batch number: M52208, expiry date: 30-JUN-2011) via intramuscular (IM) route of administration and it was offered to teachers at the school on 05-OCT-2010 at 10am. The patient has a medical history of Stevens Johnson syndrome and allergies to sulfa and pineapple. No concomitant medications were reported. On 05-OCT-2010 at 2pm, 4 hour post vaccination with the suspect drug AFLURIA, the patient complained of arm and shoulder pain at the injection site, dizziness, little nausea and lightheadedness. The patient sought medical attention by visiting a nurse and was treated with ADVIL (dose and route of administration not specified). The patient was flushed with no fever (98.8F), however her blood pressure was slightly elevated from 129/79 then went to 134/90 (units or normal range not provided). She then laid down to sleep. At around 3:30pm the patient woke complaining of itching and hives over the chest area neck which was inflamed. She was then treated with 25mg of BENADRYL (dose and route of administration not specified), at this stage her blood pressure was at 144/90 or 144/91 (units or normal range not provided). The patient then complained of her tongue swelling and was given another 25 mg of BENADRYL. The nurse took the patient to the emergency room (ER) and during this period, the teacher started to improve rapidly. The patient at the ER had light flushing, redness and a blood pressure of 155/90 (units or normal range not provided). At the ER the patient was treated with a steroid which she was to continue to take for 4 days once home, PEPCID and instructed to take BENADRYL for 24-48 hours once home (dose and route of administration not specified). The patient received FLUARIX (manufacturer unknown) last year with no problems. The patient's outcome was recovered on an unknown date. No further information provided. The case was reported as serious due to intervention and was life-threatening. The reporter did not provide a causality assessment in relation to the suspect drug, AFLURIA. The company considered events possible in relation to the suspect drug, AFLURIA. Information derived from this AE report does not change the current safety profile of the product.
A 41-year-old male patient had received an injection of Decavac, lot number not reported; an injection of IPOL, lot number not reported; an injection of Menommune, lot number not reported; an injection of Typhim VI, lot number not reported; an injection of Fluzone SV 2006-2007, lot number not reported; and an injection of Hepatitis A Vaccine, manufacturer GSK, lot number not reported; on 20 December 2006. Routes and site of administration were not reported. The patient had received the vaccinations for travel to foreign country where he visited for two weeks. Illness at the time of vaccination was unknown. "Almost immediately" post-vaccination, the patient complained of dark circles under his eyes, bags under his eyes, and a permanent tired line in his face. Per a letter from the patient dated 13 Augusut 2007, "These side effects have not improved or diminished to date." At the time of this report, the patient had not recovered. A new version was created for this case on 31 August 2007 to add that the reporter for this case is the same as for case 2007-03017. No relevant medically significant information was added.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Used partially and kept in the refrigerator) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Used partially and kept in the refrigerator). On 22-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Used partially and kept in the refrigerator) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-056309, MOD-2021-056442, MOD-2021-056507, MOD-2021-056393.
swollen knee; Did not feel well; Fever; Chills; Achiness; joint pain in arms, wrists and fingers; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient started received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on 17Oct2019 at a single dose for immunisation, and flu vaccine (influenza vaccine), via an unspecified route of administration on 17Oct2019 at a single dose for immunisation. There were no medical history and concomitant medications. The patient had fever, chills and achiness on 17Oct2019. She did not feel well on 18Oct2019. A week later on Oct2019, she developed joint pain in her arms, wrists and fingers and a swollen knee on 07Nov2019, but is still to be determined if that is part of this or something else going on. As a result, she has had cortisone injections in her shoulders and a prednisone pack for 5 days. She had cortisone injections on 31Oct2019 in her rotator cuffs on both sides due to joint pain. Then because everything snowballed, she was put on steroids (Prednisone dose pack) for 5 days which helped on 11Nov2019.  The same day of her last day of the steroid, the symptoms started coming back. She went to the ER yesterday because her knee was swollen and she hadn't been able to sleep due to prednisone. She had blood work done and it came back that she has an inflammatory issue. Outcome of the event of fever, chills and achiness was recovered on 18Oct2019, for the event of "did not feel well" was recovered on 19Oct2019, while for the remaining events was not recovered.
The patient received the first dose of Pfizer Covid 19 vaccine on 4/15/21. She was due for the second dose in the series on 5/6/21. She received the second dose on 4/30/21. The second dose was 7 days early.
9 hours after, experienced extreme headache, pressure on my eyes 12 hours later, extreme chills and body aches, headache 24 hours later chills, aches, and headache 48 hours later, swollen several lymph nodes in left neck
mom reported fever PM 3FEB93; fever inc to 105 % on Thursday 4FEB93; also rash on lt leg, back of knee, leg painful; mom took pt to pvt MD; seen by MD assistant who stated pt had allergic reaction to pertussis; advised mom not to given DTP;
Pain in arm all days, swelling in arm day 2 & 3, low grade fever on day 2 & 3, nausea on day 2 & 3, headache on day 2. Taking Ibuprofen to keep fever and headache away.